Fresenius SE & Co. KGaA

$57 USD

$2.65 (4.88%)

Volume: 165
Average Volume: 139.33
Market Capitalization: $32.1B
P/E Ratio: 15.73
Dividend Yield: 2.51%
Price Target

Year High: $58.16
Year Low: $46.21
Day High: —
Day Low: —
Payout Ratio: $0.46
Current Ratio: $1.27

Industry, Sector & symbol

Stock Exchange	OTC
CEO	Michael Sen
Industry	Medical - Care Facilities
Sector	Healthcare
Current Symbol	FSNUF
CUSIP	None
CIK	0000904868
Web	https://www.fresenius.com
Phone	49 6172 608 2487
Currency	USD
Employees	175202
Country	DE

Liquidity

Debt-to-Equity Ratio	0.60
Payout Ratio	0.46
Current Ratio	1.27
Quick Ratio	0.98
Cash Ratio	0.22

Sales & Book Value

Annual Sales	$22.86B
Price / Sales	1.02
Cash Flow	2.58
Price / Cash Flow	16.26
Price / Book	1.19

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside	%
Consensus Rating	Neutral
Rating Score(0-5)	3
Research Coverage	1 Analysts

Profitability

EPS (Most Recent Fiscal Year)	$2.25
Trailing P/E Ratio	15.73
PEG Ratio	0.06
P/E Growth	0.06
Net Income	$1.26B
Net Margin	6.38%
Pretax Margin	9.35%
Return on Equity	7.76%
Return on Assets	3.47%

Financials Score

AltmanZ Score	1.51
Piotroski Score	7.00
Working Capital	2.54B
Total Assets	42.53B
Ebit	2.22B
Market Cap	26.69B
Total Liabilities	21.99B

Poll Results

About Fresenius SE & Co. KGaA (OTC:FSNUF) Stock

Fresenius SE & Co. KGaA is a diversified healthcare enterprise delivering a broad spectrum of products and services across multiple sectors, including dialysis, hospital operations, and outpatient medical treatment. Its operations are structured into four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Fresenius Medical Care specializes in supporting individuals suffering from chronic kidney disease, supplying essential products like dialyzers, hemodialysis equipment, and associated disposable items, alongside comprehensive dialysis services. Fresenius Kabi focuses on the therapeutic management and care of acutely and chronically ill patients. Its portfolio encompasses a wide range of offerings, including intravenous generic pharmaceuticals fo ... r areas like oncology, pain management, anesthesia, infection control, and critical care. It also provides parenteral and enteral nutritional solutions, infusion fluids, blood volume expanders, and biosimilar drugs targeting autoimmune and oncological conditions. Furthermore, the segment supplies medical devices and consumables vital for administering IV medications, infusion therapies, and clinical nutrition, along with transfusion products for blood component collection and various bodily treatments. Fresenius Helios manages a substantial network of healthcare facilities. In Germany, it operates 90 hospitals, around 130 outpatient clinics, and six prevention centers. Its Spanish presence includes 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers. Additionally, this segment extends its services to fertility treatment, operating 33 dedicated clinics and 39 supplementary locations spanning ten countries across three continents. Fresenius Vamed is dedicated to project management and service provision for hospitals and other healthcare infrastructure. Its comprehensive offerings range from project conception, detailed planning, and complete turnkey construction to ongoing maintenance, technical oversight, and operational administration. Originally established in 1912, the company was previously known as Fresenius SE before adopting its current name, Fresenius SE & Co. KGaA, in January 2011. Its global headquarters are situated in Bad Homburg vor der Höhe, Germany.

Fresenius SE & Co. KGaA (FSNUY) Q1 2026 Earnings Call Transcript

2026-05-06 13:31:19

Fresenius SE & Co. KGaA (FSNUY) Q1 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Fresenius SE & Co. KGaA (FSNUF) stock price?: Fresenius SE & Co. KGaA(OTC:FSNUF) stock price is $57 in the last trading session. During the trading session, FSNUF stock reached the peak price of $58.16 while $46.21 was the lowest point it dropped to. The percentage change in FSNUF stock occurred in the recent session was 4.88% while the dollar amount for the price change in FSNUF stock was $2.65.
FSNUF's industry and sector of operation?: The OTC listed FSNUF is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
Who are the executives of FSNUF?: Michael Sen | Chief Executive Officer, President & Chairman of Management Board of Fresenius Management SE
Christian Pawlu | Member of Management Board
Sara Hennicken | Chief Financial Officer & Member of the Management Board - Fresenius Management SE
Pierluigi Antonelli | Member of Management Board of Fresenius Management SE & Chief Executive Officer of Fresenius Kabi
Robert Moller | Member of the Management Board of Fresenius Management SE
How many employees does FSNUF have?: Number of FSNUF employees currently stands at 175202. FSNUF operates from Else-Kroener-Strasse 1, Bad Homburg vor der Höhe, HE 61352, DE.

Link for FSNUF official website?: Official Website of FSNUF is: https://www.fresenius.com
How do I contact FSNUF?: FSNUF could be contacted at phone #49 6172 608 2487 and can also be accessed through its website. FSNUF operates from Else-Kroener-Strasse 1, Bad Homburg vor der Höhe, HE 61352, DE.
How many shares of FSNUF are traded daily?: The average number of FSNUF shares traded daily for last 3 months was 139.33.
What is the market cap of FSNUF currently?: The market value of FSNUF currently stands at $32.1B with its latest stock price at $57